Episode 256: Rapid-Fire Discussion of Intraoperative Management of Scleral Buckle Complications

Financial Disclosures: Dr. Sridhar is a consultant for Alcon, Dorc, Oxurion, and Regeneron. Dr. Kuriyan receives grant funding from Second Sight and Genentech/Roche and is a consultant for Alimera Sciences, Allergan, Bausch Health, Genentech/Roche, Novartis, Regeneron. Dr. Read is a consultant for Genentech. Dr. Williams has no disclosures.

Om Podcasten

An informal yet insightful commentary featuring interviews and perspectives from leaders in vitreoretinal surgery as well as the next generation of retinal specialists